Xinyang Maojian Group AI Stock Analysis
Want to see HK:0362 full AI Analyst Report?
Xinyang Maojian Group (0362) AI Stock Analysis
Xinyang Maojian Group
(HKEX:0362)
The score reflects extremely poor financial health and liquidity (the dominant factor), compounded by negative technical and valuation signals. The company's persistently negative earnings, severe balance sheet risk, and deeply bearish technical trends overwhelm any argument for near-term recovery. Lack of dividends and negative P/E reinforce the assessment that the stock is high-risk with little to no investment appeal in its current state.
Xinyang Maojian Group (0362) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 20.27M
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- -0.1
- Beta (1Y)
- 0.06
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- Hong Kong
- Employees
- 115
- Sector
- Utilities
- Sector Strength
- 66
- Industry
- Regulated Electric
Xinyang Maojian Group Business Overview & Revenue Model
Company Description
China Zenith Chemical Group Limited functions as an investment holding entity, primarily engaged in the generation and distribution of heat and power across the People's Republic of China. The company's operations are divided into three core segments...
How the Company Makes Money
Xinyang Maojian Group generates revenue through the sale of its tea products, which include both loose leaf and packaged tea varieties. The company leverages its extensive supply chain and distribution network to reach a wide range of customers, from...
Xinyang Maojian Group Financial Statement Overview
Summary
Xinyang Maojian Group demonstrates severe financial distress: revenues have sharply declined, all profitability margins except gross margin are deeply negative, and the company reports persistent, substantial net losses. The balance sheet is critically weak with negative equity suggesting insolvency risk, and cash flows are also negative, reflecting ongoing liquidity issues without operational turnaround. All standard financial health indicators are at or near their lowest possible levels.
Income Statement
2Very NegativeBalance Sheet
1Very NegativeCash Flow
4Very Negative| Breakdown | TTM | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.35M | 31.56M | 100.85M | 198.66M | 194.34M | 229.02M |
| Gross Profit | -12.81M | 11.15M | -5.10M | 32.48M | -61.06M | -25.57M |
| EBITDA | -31.45M | -39.20M | -9.27M | -30.19M | -175.57M | -162.54M |
| Net Income | -144.45M | -162.50M | -155.88M | -1.06B | -354.89M | -450.35M |
Balance Sheet | ||||||
| Total Assets | 380.92M | 478.10M | 666.63M | 1.24B | 1.93B | 2.07B |
| Cash, Cash Equivalents and Short-Term Investments | 1.19M | 30.76M | 3.01M | 14.85M | 8.82M | 47.34M |
| Total Debt | 1.12B | 1.17B | 1.17B | 1.26B | 1.13B | 1.26B |
| Total Liabilities | 1.46B | 1.49B | 1.61B | 2.06B | 1.57B | 1.98B |
| Stockholders Equity | -1.08B | -1.01B | -955.36M | -873.17M | 302.56M | 29.56M |
Cash Flow | ||||||
| Free Cash Flow | -18.44M | -8.02M | -20.77M | -69.92M | -16.58M | -76.85M |
| Operating Cash Flow | -17.26M | -5.25M | -12.76M | -26.69M | 3.08M | -58.09M |
| Investing Cash Flow | 74.23M | 642.00K | -8.42M | -34.15M | -26.09M | -27.64M |
| Financing Cash Flow | -56.67M | 32.44M | 9.59M | 26.09M | 23.98M | 126.99M |
Xinyang Maojian Group Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0362, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a bearish trend. The MACD of -0.00 indicates Neutral momentum. The RSI at is Neutral, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0362.
Xinyang Maojian Group Peers Comparison
Overall Rating
HK:068158Neutral
HK:102650Neutral
HK:036238Underperform
HK:863118Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 66Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% |
| 58Neutral | HKD 241.23M | -1.16 | -7.54% | ― | -8.96% | -597.67% | |
| 50Neutral | HKD 500.08M | -3.13 | -30.39% | ― | 4.98% | -59.49% | |
| 38Underperform | HKD 20.27M | -0.07 | 16.55% | ― | ― | ― | |
| 18Underperform | HKD 20.64M | -5.16 | 30.27% | ― | ― | ― |
* Utilities Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:0362 | Xinyang Maojian Group | 0.01 | 0.00 | 0.00% | |
| HK:1026 | Universal Technologies Holdings Limited | 0.09 | -0.01 | -10.78% | |
| HK:0681 | Chinese People Holdings Co. Ltd. | 0.03 | -0.01 | -25.00% | |
| HK:8631 | Sun Kong Holdings Ltd. | 0.43 | -0.05 | -10.42% | |
| HK:2481 | Wise Living Technology Co., Ltd Class H | 2.56 | 0.09 | 3.77% | |
| HK:2655 | Guoxia Technology Co., Ltd. Class H | 10.26 | -33.54 | -76.58% |
Xinyang Maojian Group Corporate Events
China Zenith Chemical Faces Continued Suspension and Delisting Risk as Liquidators Review Operations
China Zenith Chemical Group Limited, a Hong Kong-listed chemical manufacturer now in compulsory liquidation, is under the control of joint and several liquidators who are still assessing the state of its business by examining available books and reco...
China Zenith Chemical Group Appoints Liquidators Amidst Operational Changes
China Zenith Chemical Group Limited, currently in compulsory liquidation, has appointed Osman Mohammed Arab and Lai Wing Lun as joint and several liquidators following a High Court order. The company has also announced a change in its principal place...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Jul 25, 2025
